⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL209652 | 1.00 | — | — | |
| SCHEMBL6067714 | 1.00 | — | — | |
| Isopropylamine SCHEMBL1193775 | 0.76 | — | — | |
| SCHEMBL10723942 | 0.72 | — | — | |
| SCHEMBL77706 | 0.72 | — | — | |
| SCHEMBL1064989 | 0.72 | — | — | |
| SCHEMBL2995 | 0.70 | — | — | |
| SCHEMBL652953 | 0.70 | — | — | |
| Isopropylamine SCHEMBL2896130 | 0.70 | — | — | |
| Isopropylamine SCHEMBL10740624 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2809647-B1 | MGLU 2/3 AGONISTS | LILLY CO ELI (US) | 2016-07-06 | — | — | EP | claimed |
| EP-2721012-B1 | BICYCLO(3.1.0)HEXANE-2,6-DICARBOXYLIC ACID DERIVATIVES AS MGLU2 RECEPTOR AGONIST | LILLY CO ELI (US) | 2016-05-25 | — | — | EP | claimed |
| US-9296710-B2 | Bicyclo (3.1.0) hexane-2, 6-dicarboxylic acid derivatives as mGlu2 receptor agonist | ELI LILLY AND COMPANY (US) | 2016-03-29 | — | — | US | claimed |
| CN-102898330-B | Colchicine derivatives | UNIV ZHEJIANG | 2015-02-25 | — | — | CN | claimed |
| CN-104230937-A | Colchicine derivative | UNIV ZHEJIANG | 2014-12-24 | — | — | CN | claimed |
| EP-2809647-A1 | MGLU 2/3 AGONISTS | Eli Lilly and Company (US) | 2014-12-10 | — | — | EP | claimed |
| US-20140113944-A1 | BICYCLO (3.1.0) HEXANE-2, 6-DICARBOXYLIC ACID DERIVATIVES AS MGLU2 RECEPTOR AGONIST | ELI LILLY AND COMPANY (US) | 2014-04-24 | — | — | US | claimed |
| EP-2721012-A1 | BICYCLO (3.1.0) HEXANE- 2, 6 -DICARBOXYLIC ACID DERIVATIVES AS MGLU2 RECEPTOR AGONIST | Eli Lilly and Company (US) | 2014-04-23 | — | — | EP | claimed |
| US-8575214-B2 | MGlu 2/3 agonists | ELI LILLY AND COMPANY (US) | 2013-11-05 | — | — | US | claimed |
| EP-2516406-B1 | MGLU2 AGONISTS | LILLY CO ELI (US) | 2013-09-18 | — | — | EP | claimed |
| CN-1041919-C | N-(3-piperidinylcarbonyl)-beta-alanine derivatives as PAF antagonists | FUJISAWA PHARMACEUTICAL CO (JP) | 1999-02-03 | — | — | CN | claimed |
| EP-0869944-A1 | N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-10-14 | — | — | EP | claimed |
| WO-1996029309-A1 | N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-09-26 | — | — | WO | claimed |
| CN-1116847-A | N- (3-piperidinylcarbonyl) -beta-aminopropionic acid derivatives as PAF antagonists | FUJISAWA PHARMACEUTICAL CO (JP) | 1996-02-14 | — | — | CN | claimed |
| EP-0669912-A1 | N-(3-PIPERIDINYLCARBONYL)-BETA-ALANINE DERIVATIVES AS PAF ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-09-06 | — | — | EP | claimed |
| WO-1995008536-A1 | N-(3-PIPERIDINYLCARBONYL)-BETA-ALANINE DERIVATIVES AS PAF ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-03-30 | — | — | WO | claimed |
| EP-0413209-A1 | LHRH analogs | TAP Pharmaceuticals Inc. (US) | 1991-02-20 | — | — | EP | claimed |
| EP-0114091-B1 | COATING COMPOSITION COMPRISING BIS-DIENE OLIGOMERS AND BIS-DIENEOPHILE OLIGOMERS | FORD MOTOR COMPANY LIMITED (GB) | 1986-11-05 | — | — | EP | claimed |
| US-4515926-A | Coating composition comprising bis-diene oligomers and bis-dieneophile oligomers | FORD MOTOR COMPANY (US) | 1985-05-07 | — | — | US | claimed |
| EP-0114091-A1 | Coating composition comprising bis-diene oligomers and bis-dieneophile oligomers | FORD MOTOR COMPANY LIMITED (GB) | 1984-07-25 | — | — | EP | claimed |